XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Total stockholders' equity
Common stock 
Capital surplus
(Accumulated deficit) retained earnings
Treasury stock
Cumulative translation adjustment
Defined benefit postretirement plans
Cash flow hedging derivative
Non-controlling interest
Balance at beginning of period at Dec. 31, 2023 $ 3,431.6 $ 3,419.1 $ 0.0 $ 4,429.2 $ (811.1) $ (0.3) $ (153.0) $ (62.2) $ 16.5 $ 12.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (37.6) (39.6)     (39.6)         2.0
Equity-based compensation plans 25.2 25.2   25.2            
Dividends declared (44.0) (44.0)   (44.0)            
Shares acquired under stock repurchase program (9.4) (9.4)       (9.4)        
Pension adjustments, net of tax benefit (0.9) (0.9)           (0.9)    
Change in cumulative translation adjustment, net of tax benefit (expense) (36.0) [1] (35.8)         (35.8)     (0.2)
Net investment hedge derivative, net of tax expense (benefit) 8.4 [2] 8.4         8.4      
Cash flow hedge derivative, net of tax expense (benefit) 4.3 [3] 4.3             4.3  
Balance at end of period at Jun. 30, 2024 3,341.6 3,327.3 0.0 4,410.4 (850.7) (9.7) (180.4) (63.1) 20.8 14.3
Balance at beginning of period at Mar. 31, 2024 3,369.1 3,355.4 0.0 4,414.9 (834.3) (0.3) (183.5) (62.6) 21.2 13.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (15.7) (16.4)     (16.4)         0.7
Equity-based compensation plans 17.6 17.6   17.6            
Dividends declared (22.1) (22.1)   (22.1)            
Shares acquired under stock repurchase program (9.4) (9.4)       (9.4)        
Pension adjustments, net of tax benefit (0.5) (0.5)           (0.5)    
Change in cumulative translation adjustment, net of tax benefit (expense) (0.5) [1] (0.4)         (0.4)     (0.1)
Net investment hedge derivative, net of tax expense (benefit) 3.5 [2] 3.5         3.5      
Cash flow hedge derivative, net of tax expense (benefit) (0.4) [3] (0.4)             (0.4)  
Balance at end of period at Jun. 30, 2024 3,341.6 3,327.3 0.0 4,410.4 (850.7) (9.7) (180.4) (63.1) 20.8 14.3
Balance at beginning of period at Dec. 31, 2024 3,314.4 3,298.5 0.0 4,394.0 (839.7) (9.7) (211.4) (62.6) 27.9 15.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (47.4) (49.5)     (49.5)         2.1
Equity-based compensation plans 18.0 18.0   18.0            
Dividends declared (22.1) (22.1)   (22.1)            
Pension adjustments, net of tax benefit (0.8) (0.8)           (0.8)    
Change in cumulative translation adjustment, net of tax benefit (expense) 147.4 [1] 146.8         146.8     0.6
Net investment hedge derivative, net of tax expense (benefit) (60.8) [2] (60.8)         (60.8)      
Cash flow hedge derivative, net of tax expense (benefit) (22.5) [3] (22.5)             (22.5)  
Balance at end of period at Jun. 30, 2025 3,326.2 3,307.6 0.0 4,389.9 (889.2) (9.7) (125.4) (63.4) 5.4 18.6
Balance at beginning of period at Mar. 31, 2025 3,310.5 3,293.4 0.0 4,374.4 (855.5) (9.7) (167.2) (63.0) 14.4 17.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (32.6) (33.7)     (33.7)         1.1
Equity-based compensation plans 15.5 15.5   15.5            
Pension adjustments, net of tax benefit (0.4) (0.4)           (0.4)    
Change in cumulative translation adjustment, net of tax benefit (expense) 87.1 [1] 86.7         86.7     0.4
Net investment hedge derivative, net of tax expense (benefit) (44.9) [2] (44.9)         (44.9)      
Cash flow hedge derivative, net of tax expense (benefit) (9.0) [3] (9.0)             (9.0)  
Balance at end of period at Jun. 30, 2025 $ 3,326.2 $ 3,307.6 $ 0.0 $ 4,389.9 $ (889.2) $ (9.7) $ (125.4) $ (63.4) $ 5.4 $ 18.6
[1] Tax Expense (Benefit) of $4.4 million and $(0.3) million for the three months ended June 30, 2025 and 2024, respectively. Tax Expense (Benefit) of $(1.1) million and $0.3 million for the six months ended June 30, 2025 and 2024, respectively.
[2] Tax Expense (Benefit) of $(16.0) million and $1.2 million for the three months ended June 30, 2025 and 2024, respectively. Tax Expense (Benefit) of $(21.8) million and $2.9 million for the six months ended June 30, 2025 and 2024, respectively.
[3] Tax Expense (Benefit) of $(3.2) million and $(0.1) million for the three months ended June 30, 2025 and 2024, respectively. Tax Expense (Benefit) of $(8.1) million and $1.5 million for the six months ended June 30, 2025 and 2024, respectively.